HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.

Abstract
Anaplastic thyroid cancer is an extremely aggressive disease resistant to radioiodine treatment because of loss of sodium iodide symporter (NIS) expression. To enhance prognosis of this fatal cancer, we validated the preclinical efficacy of measles virus (MV)-NIS, the vaccine strain of the oncolytic MV (MV-Edm), modified to include the NIS gene. Western blotting analysis confirmed that a panel of eight anaplastic thyroid cancer (ATC)-derived cell lines do not express NIS protein, but do express CD46, the MV receptor. In vitro cell death assays and in vivo xenograft studies demonstrate the oncolytic efficacy of MV-NIS in BHT-101 and KTC-3, ATC-derived cell lines. Radioactive iodine uptake along with single-photon emission computed tomography (SPECT)-computed tomography imaging of KTC-3 xenografts after (99)Tc(m) administration confirmed NIS expression in vitro and in vivo, respectively, after virus treatment. Adjuvant administration of RAI, to MV-NIS-treated KTC-3 tumors showed a trend for increased tumor cell killing. As current treatment for ATC is only palliative, and MV-NIS is currently Food and Drug Administration approved for human clinical trials in myeloma, our data indicate that targeting ATC with MV-NIS could prove to be a novel therapeutic strategy for effective treatment of iodine-resistant ATC and will expedite its testing in clinical trials for this aggressive disease.
AuthorsH V Reddi, P Madde, S J McDonough, M A Trujillo, J C Morris 3rd, R M Myers, K W Peng, S J Russell, B McIver, N L Eberhardt
JournalCancer gene therapy (Cancer Gene Ther) Vol. 19 Issue 9 Pg. 659-65 (Sep 2012) ISSN: 1476-5500 [Electronic] England
PMID22790962 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD46 protein, human
  • Iodine Radioisotopes
  • Membrane Cofactor Protein
  • Receptors, Virus
  • Symporters
  • sodium-iodide symporter
  • Iodine
Topics
  • Animals
  • Blotting, Western
  • Cell Line, Tumor
  • Chlorocebus aethiops
  • Female
  • Genetic Therapy (methods)
  • Humans
  • Iodine (metabolism)
  • Iodine Radioisotopes (metabolism, therapeutic use)
  • Measles virus (genetics, metabolism)
  • Membrane Cofactor Protein (genetics, metabolism)
  • Mice
  • Mice, Nude
  • Oncolytic Virotherapy (methods)
  • Oncolytic Viruses (genetics, metabolism)
  • Receptors, Virus (metabolism)
  • Symporters (genetics, metabolism, therapeutic use)
  • Thyroid Carcinoma, Anaplastic
  • Thyroid Neoplasms (diagnostic imaging, metabolism, therapy)
  • Tomography, Emission-Computed, Single-Photon
  • Vero Cells
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: